GENE ONLINE|News &
Opinion
Blog

Deals
Hoping to Boost Revenue Growth, Gilead Acquires MYR in a $1.4 B Deal
2020-12-13
AstraZeneca to Acquire Alexion for US$ 39 Billion to Grow Immunology Pipeline
2020-12-13
JD Health Debuts in HKEx, Possibly Landing a 3.5 Billion IPO
2020-12-10
2020-China’s Biomedicine Industry Ushers New Upsurge of IPO listings
2020-12-07
Genesis Bags $52M Series A to Employ AI for Drug Discovery and Development
2020-12-06
AstraZeneca Sells its Cholesterol Drug to German Pharma
2020-12-03
Kinaset Therapeutics Debuts in the Asthma Market with $40 Million Financing
2020-12-02
Ginkgo Receives $1.1B from the US Government to Fight Pandemics
2020-11-29
RESILIENCE Launches with an Aim to Overcome Limitations of Traditional Manufacturing
2020-11-25
Merck Spends $425 Million to Acquire OncoImmune’s COVID-19 Therapy
2020-11-24
D3 Bio Launches with $200 Million to Advance Precision Medicine in Oncology and Immunology Space
2020-11-22
R&D
BioMarin Collaborates with Canadian Biotech for AI-based Drug Discovery
2020-11-22
Elevation Oncology Raises $65 M to Repurpose Failed Drug for Genomically Defined Tumors
2020-11-20
FMI Empowers its Genomic Cancer Testing by Licensing TwinStrand’s Duplex Sequencing Technology
2020-11-18
Kira Launches with $46 Million to Combat Complement-Mediated Diseases
2020-11-15
1 38 39 40 41 42 47
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top